Alliance Pharma Plc

Alliance Pharma (APH)

Trade Now

Capital at risk Advertisement
Company name:Alliance Pharma Plc
EPIC:APHTrading Currency:GBX
Market Sector:AS50ISIN:GB0031030819
Market Segment:AMSMShare Type:DE
WWW Address:Description:ORD 1P
 Price Price Change [%] Bid Offer Open High Low Volume
 55.70 -2.5 [-4.30] 55.50 55.70 59.50 59.50 55.30 2,273,616
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 300.44 539.39 0.02 1.37 1.68 40.66 3.02 122.00 - 55.10

Alliance Pharma Key Figures

(at previous day's close)
Market Cap.300.44m
Shares In Issue539.39m
Prev. Close58.20
PE Ratio40.66 
Dividend Yield3.02%
EPS - basic1.37p
Dividend PS1.68p
Dividend Cover0.82 
Cash Flow PS7.17p
Return On Equity (ROE)2.59%
Operating Margin11.13%
PEG Factor-3.68 
EPS Growth Rate-11.04%
Dividends PS Growth Rate4.35%
Net Debt191.94m
Gross Gearing43.89%
Quick Assets63.47m
Net Working Capital43.97m
Intangibles / Fixed Assets98.76%
Turnover PS30.26p
Pre-Tax Profit PS3.37p
Retained Profit PS-0.24p
Cash PS5.39p
Net Cash PS-2.14p
Net Tangible Asset Value PS *-24.33p
Net Asset Value PS52.37p
Spread0.20 (0.36%) 

Alliance Pharma Balance Sheet


Share Price Performance

Sample Period HighLow
1 week67.5055.10
4 weeks95.9055.10
12 weeks120.0055.10
1 year122.0055.10

Share Price Chart (5 years)

Alliance Pharma Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week67.50-11.80-17.4855.103.4858.69
4 weeks95.00-39.30-41.3755.102.3569.49
12 weeks116.60-60.90-52.2355.102.1289.59
26 weeks118.60-62.90-53.0455.101.6098.94
1 year102.80-47.10-45.8255.101.19101.39
3 years73.20-17.50-23.9155.101.1889.58
5 years54.750.951.7454.251.1584.66

Alliance Pharma Key Management Ratios

Alliance Pharma Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio51.38 
PE Ratio40.66 
Tobin's Q Ratio 0.59 
Tobin's Q Ratio (excl. intangibles)3.24 
Dividend Yield3.02%
Market-to-Book Ratio1.06 
Price-to-Pre-Tax Profit PS16.55 
Price-to-Retained Profit PS-233.80 
Price-to-Cash Flow PS7.77 
Price-to-Sales PS1.84 
Price-to-Net Tangible Asset Value PS-2.29 
Price-to-Cash PS10.34 
Net Working Capital PS8.15 
Price Pct to Working Capital PS6.83%
Earnings Yield2.46%
Average PE36.41 
Years in average5 
PE to PE average111.67%

Alliance Pharma Financial Ratios

(Leverage Ratios)
Debt Ratio38.98%
Debt-to-Equity Ratio0.64 
Debt-to-Equity Ratio (excl. Intgbl)-1.37 
Debt-to-Equity Market Value0.60 
Net Gearing38.12%
Net Gearing (excl. Intangibles)213.88%
Gross Gearing43.89%
Gross Gearing (excl. Intangibles)246.26%
Gearing Under 1 Year8.06%
Gearing Under 1 Year (excl. Intgbl)45.21%
(Liquidity Ratios)
Net Working Capital to Total Assets8.73%
Current Ratio2.08 
Quick Ratio (Acid Test)1.56 
Liquidity Ratio0.72 
Cash & Equiv/Current Assets34.37%
(Solvency Ratios)
Enterprise Value451.80m
CFO/Attributable Profit5.28 
Total Debt/Equity Market Value0.74 
Total Debt/Sales1.35 
Total Debt/Pre-Tax Profit12.17 
Total Debt221.00m
Total Debt/Net Current Assets5.03%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs9 
Beta (60-Mnth)Beta (36-Mnth)

Alliance Pharma Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)3.92%
Return On Assets (ROA)1.45%
Net Profit Margin4.48%
Assets Turnover0.32 
Return On Equity (ROE)2.59%
Return On Investment (ROI)1.55%
Dividend Payout Ratio122.63%
Plowback Ratio-22.63%
Growth from Plowback Ratio-0.59%
Net Income Of Revenues-0.79%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.58 
Fixed Assets Turnover0.38 
Current Assets Turnover2.00 
Net Working Capital Turnover 
Inventory Turnover7.42 
(Other Operating Ratios)
Total Assets-to-Sales3.10 
Debt Collection Period68.88Days

Alliance Pharma Dividends

Announcement DateTypeCurr.Dividend AmountPeriod StartPeriod EndEx DateRecord DatePayment DateTotal Dividend Amount
22 Mar 2022FinalGBX1.1331/12/202031/12/202109/06/202210/06/202207/07/20221.68
21 Sep 2021InterimGBX0.5631/12/202031/12/202123/12/202124/12/202107/01/2022-
23 Mar 2021FinalGBX1.0831/12/201931/12/202010/06/202111/06/202108/07/20211.61
22 Sep 2020InterimGBX0.5331/12/201931/12/202017/12/202018/12/202007/01/2021-
24 Sep 2019InterimGBX0.5431/12/201831/12/201919/12/201920/12/201910/01/20200.54
26 Mar 2019FinalGBX0.9831/12/201731/12/201813/06/201914/06/201911/07/20191.47
19 Sep 2018InterimGBX0.4931/12/201731/12/201820/12/201821/12/201810/01/2019-
27 Mar 2018FinalGBX0.8931/12/201631/12/201714/06/201815/06/201811/07/20181.33
13 Sep 2017InterimGBX0.4431/12/201631/12/201721/12/201722/12/201711/01/2018-
29 Mar 2017FinalGBX0.8131/12/201531/12/201615/06/201716/06/201712/07/20171.21
14 Sep 2016InterimGBX0.4031/12/201531/12/201622/12/201623/12/201612/01/2017-
07 Apr 2016FinalGBX0.7431/12/201431/12/201516/06/201617/06/201613/07/20161.10
09 Sep 2015InterimGBX0.3631/12/201431/12/201524/12/201529/12/201514/01/2016-
25 Mar 2015FinalGBX0.6731/12/201331/12/201418/06/201519/06/201515/07/20151.00
10 Sep 2014InterimGBX0.3331/12/201331/12/201403/12/201405/12/201415/01/2015-
26 Mar 2014FinalGBX0.6131/12/201231/12/201311/06/201413/06/201410/07/20140.91
11 Sep 2013InterimGBX0.3031/12/201231/12/201304/12/201306/12/201315/01/2014-
21 Mar 2013FinalGBX0.5531/12/201131/12/201212/06/201314/06/201311/07/20130.83
12 Sep 2012InterimGBX0.2831/12/201131/12/201205/12/201207/12/201215/01/2013-
22 Mar 2012FinalGBX0.5031/12/201031/12/201113/06/201215/06/201212/07/20120.75
07 Sep 2011InterimGBX0.2531/12/201031/12/201130/11/201102/12/201113/01/2012-
23 Mar 2011FinalGBX0.4031/12/200931/12/201015/06/201117/06/201114/07/20110.57
08 Sep 2010InterimGBX0.1731/12/200931/12/201001/12/201003/12/201014/01/2011-
24 Mar 2010FinalGBX0.2331/12/200831/12/200916/06/201018/06/201015/07/20100.30
09 Sep 2009InterimGBX0.0730/12/200830/06/200902/12/200904/12/200915/01/2010-

Alliance Pharma Fundamentals

 31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)31 Dec 2021 (GBP)
pre tax profit22.8019.29%32.8924.25%13.0210.03%18.1611.13%m
attributable profit18.3615.53%26.4819.52%8.036.18%7.324.48%m
retained profit12.0110.16%18.8813.92%5.194.00%-1.29-0.79%m
eps - basic (p)3.69 5.09 1.54 1.37 
eps - diluted (p)3.60 4.99 1.52 1.35 
dividends per share1.47 0.54 1.61 1.68 

Alliance Pharma Balance Sheet

 31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)31 Dec 2021 (GBP)
 31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)31 Dec 2021 (GBP)
fixed assets fixed assets7.591.88%11.552.83%15.923.13%4.830.96%m
intangibles intangibles335.2483.06%328.6680.63%412.8781.14%413.7482.18%m
fixed investments fixed investments0.180.04%1.370.34%0.990.19%0.370.07%m
current assets - other current assets - other--%--%--%0.060.01%m
stocks stocks18.714.63%15.523.81%22.924.50%21.084.19%m
debtors debtors30.997.68%32.708.02%27.255.36%34.356.82%m
cash & securities cash & securities10.892.70%17.834.37%28.905.68%29.065.77%m
creditors - short creditors - short91.7222.73%24.215.94%30.195.93%40.588.06%m
creditors - long creditors - long59.6914.79%109.2526.80%197.7138.85%180.4235.84%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
ord cap, reserves ord cap, reserves252.2062.49%274.1867.26%280.9655.21%282.4956.11%m
prefs, minorities prefs, minorities--%--%--%--%m
NAV Basic- - - - 
NAV Diluted- - - - 

Alliance Pharma Cash Flow Statement

31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)31 Dec 2021 (GBP)
Operating CF22.1735.7641.5738.66m
Pre-Financing CF-36.9132.47-44.3034.06m
Retained CF-0.337.2811.45-0.28m

Alliance Pharma Brokers

Evolution Securities LimitedMarket Maker(MMF)Broker/DealerEVOEVBGGB21MMT
Numis Securities LimitedMarket Maker(MMF)Broker/DealerNUMSRAZHGB2LBIC
Shore Capital Stockbrokers LtdMarket Maker(MMF)Broker/DealerSCAPSHOCGB21
Winterflood Securities LtdMarket Maker(MMF)Broker/DealerWINSWNTSGB2LBIC
ADVFN Advertorial
Your Recent History
Alliance P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20220929 17:04:31